CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 46 filers reported holding CONMED CORP in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,322,430 | +11.2% | 32,244,000 | +48.3% | 0.17% | +1.2% |
| Q2 2023 | $33,550,992 | +62.4% | 21,744,000 | +29.9% | 0.17% | +59.6% |
| Q1 2023 | $20,653,724 | +13.5% | 16,744,000 | +4.7% | 0.10% | -21.8% |
| Q4 2022 | $18,201,172 | +10.5% | 15,994,000 | +6.9% | 0.13% | +34.3% |
| Q3 2022 | $16,470,000 | +64.5% | 14,959,000 | +81.2% | 0.10% | +102.0% |
| Q2 2022 | $10,012,000 | -89.2% | 8,254,000 | -84.7% | 0.05% | -80.9% |
| Q1 2022 | $93,024,000 | +17.5% | 53,974,000 | +13.7% | 0.26% | +93.9% |
| Q4 2021 | $79,163,000 | +25.4% | 47,474,000 | +16.6% | 0.13% | +5.6% |
| Q3 2021 | $63,148,000 | +12.5% | 40,724,000 | +17.3% | 0.12% | -1.6% |
| Q2 2021 | $56,123,000 | +240.9% | 34,724,000 | +230.7% | 0.13% | +159.2% |
| Q1 2021 | $16,465,000 | – | 10,500,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mohican Financial Management, LLC | 2,840,000 | $3,958,000 | 4.02% |
| ZAZOVE ASSOCIATES LLC | 13,564,000 | $18,956,000 | 2.33% |
| SHENKMAN CAPITAL MANAGEMENT INC | 10,584,000 | $15,014,000 | 1.57% |
| SSI INVESTMENT MANAGEMENT LLC | 8,349,000 | $11,673,000 | 0.83% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 8,930,000 | $12,528,000 | 0.75% |
| MACKAY SHIELDS LLC | 32,384,000 | $45,397,000 | 0.31% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 8,379,000 | $11,734,000 | 0.25% |
| PALISADE CAPITAL MANAGEMENT, LP | 5,271,000 | $7,387,000 | 0.19% |
| Calamos Advisors LLC | 23,007,000 | $32,262,000 | 0.19% |
| WESTWOOD HOLDINGS GROUP INC | 10,200,000 | $14,415,000 | 0.17% |